Atrial premature beat, ventricular premature beat
Conditions
Interventions
Observation group:On the basis of routine western medicine treatment, take Xinsuning capsule or Xinsuning capsule alone
Sponsors
Beijing hospital
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1. For patients with ventricular premature beats, the main symptom is palpitation or chest tightness. The ECG diagnosis is in line with the patients with ventricular premature beats in diagnostics (Ninth Edition), and 24h ambulatory ECG examination shows that the number of ventricular premature beats is more than 2000 times / 24h; For asymptomatic patients, ventricular premature beats load >= 5% [6] (premature beats load is the percentage of premature beats in the recorded total heart beats: 24h premature beats / 24h total heart beats * 100%) 2. Patients with atrial premature beats, whose main symptom is palpitation or chest tightness, whose ECG diagnosis is in line with the patients with atrial premature beats in diagnostics (Ninth Edition), and 24h ambulatory ECG examination, the number of episodes of atrial premature beats > 2000 times / 24h; If there are no symptoms, the ECG diagnosis is consistent with the patients with atrial premature beats in diagnostics (Ninth Edition), and the ventricular premature beat load of 24h ambulatory ECG is >= 5% 3. Patient aged >= 18 and <= 85 years; 4. Gender unlimited; 5. Sign informed consent and participate in the trial voluntarily.
Exclusion criteria
Exclusion criteria: 1. Allergic to known ingredients of the test drug and allergic constitution; 2. Pregnant and lactating women, who are preparing for pregnancy recently; 3. In primary liver, kidney or hematopoietic system diseases, the levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were > 2 times of the upper limit of normal or the level of serum creatinine was 1.5 times higher than the upper limit of normal; 4. Long term alcoholics, drug addicts and patients with mental diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction of total frequency of premature beats detected by 24h ambulatory electrocardiogram;Remission of premature beat related symptoms (palpitation, chest tightness) (VAS score); | — |
Secondary
| Measure | Time frame |
|---|---|
| Recurrence rate within one year after the end of treatment observation period;TCM syndrome score;blood sugar;blood fat;glycosylated hemoglobin;Blood potassium;Blood sodium;Blood magnesium;NTproBNP;BNP; | — |
Countries
China
Contacts
Public ContactJiefu Yang
Outcome results
None listed